Abstract

Psoriasis is chronic skin disease and an important health concern. Traditional Chinese Medicine (TCM) has shown great promise in the treatment of psoriasis. However, the correlation between TCM Syndromes and genomics of psoriasis has not been evaluated. Here, we analyzed gene expression profiling of monocytes from psoriasis vulgaris patients with different TCM syndrome types to reveal the molecular basis of different psoriasis syndromes. Of the 62 cases of psoriasis vulgaris recruited, 16, 23, and 23 cases were of blood-heat syndrome, blood stasis syndrome, and blood-dryness syndrome, respectively; 10 healthy controls were recruited as controls. Affymertix’s Gene Chip ®clariom D gene chip was used to detect the gene expression profile of peripheral blood monocytes collected from recruited individuals. Compared with the healthy control group, 1570 genes were up-regulated and 977 genes were down-regulated in the psoriasis vulgaris patients group; 798 genes and 108 genes were up- and down-regulated in the blood-heat syndrome group respectively; 319 and 433 genes were up- and down-regulated in the blood-dryness syndrome group, respectively; and 502 and 179 genes were up-and down-regulated in the blood-stasis syndrome group. Our analyses indicated not only common differential genes and pathways between psoriasis syndrome groups and healthy controls, but also syndrome-specific genes and pathways. The results of this study link the three syndromes at the gene level and will be useful for clarifying the molecular basis of TCM syndromes of psoriasis. Clinical Trial Registration: (http://www.chictr.org.cn/showproj.aspx?proj=4390), identifier (ChiCTR-TRC-14005185).

Highlights

  • Psoriasis is a chronic proliferative skin disease mediated by abnormal immune system, which is determined by polygenic inheritance and stimulated by multiple environmental factors

  • We further examined the differences in gene expression among the three syndromes in order to reveal the molecular basis of the different syndromes of psoriasis at the gene level

  • The diagnostic criteria were in line with those described for psoriasis vulgaris (Boehncke and Schön, 2015); the Traditional Chinese Medicine (TCM) diagnosis was consistent with that of bai bi (TCM disease name for psoriasis)

Read more

Summary

Introduction

Psoriasis is a chronic proliferative skin disease mediated by abnormal immune system, which is determined by polygenic inheritance and stimulated by multiple environmental factors. PSORI-CM02 and FZHFZY has been used for decades to treat blood stasis and blood dryness syndromes of psoriasis vulgaris at the Guangdong Provincial Hospital of Chinese Medicine (Lu et al, 2019; Lu et al, 2021a; Lu et al, 2021b). PSORI-CM02 consists of Rhizoma Curcumae (Curcuma longa L.), Radix Paeoniae rubra (Paeonia lactiflora Pall.), Sarcandra glabra [Sarcandra glabra (Thunb.) Nakai], Rhizoma Smilacis glabrae (Smilax glabra Roxb.), and Fructus mume [Prunus mume (Siebold) Siebold & Zucc.] (the ratio was 2: 3: 5: 5: 2). FZHFZY includes Radix seu Herba Cynanchi Paniculati (Vincetoxicum mukdenense Kitag.), Densefruit Pittany Rootbark (Dictamnus dasycarpus Turcz.), Fructus Cnidii [Cnidium monnieri (L.) Cusson], Rhizoma Smilacis Glabrae (Smilax glabra Roxb.), Radix Rehmanniae Preparata [Rehmannia glutinosa (Gaertn.) DC.], Radix Angelicae Sinensis [Angelica sinensis (Oliv.) Diels], and Pericarpium Punicae Granati (Punica granatum L.) (the ratio was 3: 3: 2: 3: 3: 2: 3)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.